title: Evaluation of the effects of single-nucleotide polymorphisms in CYP3A4 and CYP4F2 on stable phenprocoumon and acenocoumarol maintenance doses.
authors.forename: R M F
authors.initials: RM
authors.lastname: van Schie
authors.forename: A
authors.initials: A
authors.lastname: Aoussar
authors.forename: F J M
authors.initials: FJ
authors.lastname: van der Meer
authors.forename: A
authors.initials: A
authors.lastname: de Boer
authors.forename: A H
authors.initials: AH
authors.lastname: Maitland-van der Zee
mesh_terms: D000074:Acenocoumarol / Q000008:administration & dosage*; D000465:Algorithms; D000925:Anticoagulants / Q000008:administration & dosage*; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000235:genetics; D003430:Cross-Sectional Studies; D051544:Cytochrome P-450 CYP3A / Q000235:genetics*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D000072470:Cytochrome P450 Family 4; D004334:Drug Administration Schedule; D005838:Genotype; D006801:Humans; D010597:Pharmacogenetics; D010644:Phenprocoumon / Q000008:administration & dosage*; D020641:Polymorphism, Single Nucleotide; D014652:Vascular Diseases / Q000235:genetics / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D003577:Cytochrome P-450 Enzyme System; D051544:Cytochrome P-450 CYP3A; D000072470:Cytochrome P450 Family 4; C510163:CYP3A4 protein, human; C117480:CYP4F2 protein, human; D000074:Acenocoumarol; D010644:Phenprocoumon